A Study to Evaluate the Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir When Administered Together in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Danoprevir (Primary) ; Efavirenz; Ritonavir
- Indications Hepatitis C; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Roche
- 12 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 May 2012 New trial record